Predicting STIs in people on HIV PrEP in Spain
Part of Infections clinical trials.
This study is for people in Spain who are starting or already taking PrEP pills to prevent HIV. It aims to create a tool that can help predict who might get a sexually transmitted infection while on PrEP, so doctors can offer better monitoring or prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older.
- You do not have HIV.
- You are taking or will take daily or event-driven PrEP pills to prevent HIV.
- You belong to a group with higher HIV risk (e.g., a man who has sex with men, a transgender woman, a sex worker, a person who injects drugs, or someone with multiple sexual partners).
- You have had at least one sexually transmitted infection in the past year (if you are a man who has sex with men or a transgender woman).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
This study offers free testing for several viruses, including hepatitis C, for gay and bisexual men and transgender women in Spain. It aims to connect people who test positive with care and treatment, especially if you are taking or waiting for PrEP.
This study looks at how taking PrEP (medicine to prevent HIV) affects HIV prevention and how much it costs in real life. You may be able to join if you are HIV-negative and are interested in starting, currently using, or have used PrEP before.
This study helps transgender women who are not regularly using PrEP (a daily pill to prevent HIV) get access to HIV prevention services. It uses a smartphone to take pictures and connect with support.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
Hear when a new Sexually Transmitted Infections (STIs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.